BioSpace News Archive

Business

CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for the third quarter of 2022.

November 14, 2022
·
10 min read
Business

Enanta Pharmaceuticals to Host Conference Call on November 21 at 4:30 p.m. ET to Discuss its Financial Results for Its Fiscal Fourth Quarter and Full Year Ended September 30, 2022

Enanta Pharmaceuticals, Inc. today announced that it plans to report its financial results for its fiscal fourth quarter and full year ended September 30, 2022 after the U.S. market closes on November 21, 2022.

November 14, 2022
·
1 min read
Business

Exscientia and MD Anderson Launch Strategic Collaboration to Leverage AI in Developing Novel Oncology Treatments

Exscientia plc (Nasdaq: EXAI) and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration to align the patient-centric artificial intelligence (AI) capabilities of Exscientia with the drug discovery and development expertise of MD Anderson in order to advance novel small-molecule oncology therapies.

November 14, 2022
·
6 min read
Business

908 Devices Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Outlook

908 Devices Inc. today reported financial results for the quarter ended September 30, 2022.

November 14, 2022
·
7 min read
FDA

PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns

PerkinElmer Inc. today announced that the U.S. Food and Drug Administration (FDA) has authorized the marketing of the EONIS™ SCID-SMA assay kit for in vitro diagnostic (IVD) use by certified laboratories for the simultaneous detection of spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) in newborns.

November 14, 2022
·
3 min read
Business

Alice Zhang, CEO & Co-founder of Verge Genomics, Recognized Today by Both Fortune and Fierce Biotech as a Pioneer in AI-Driven Drug Discovery

Verge Genomics announced that Alice Zhang, CEO and co-founder of Verge Genomics, has been named to both Fortune’s 2022 40 Under 40 list of rising business influencers and Fierce Biotech’s list of the 2022 Fiercest Women in Life Sciences.

November 14, 2022
·
3 min read
Genetown

VBI Vaccines to Participate in Upcoming Investor Conferences - November 14, 2022

VBI Vaccines Inc. today announced that members of the management team will participate in analyst-led fireside chats at the following investor conferences.

November 14, 2022
·
4 min read
Pharm Country

Teva Announces Unique Collaboration with Rimidi to Expand the Reach of its Respiratory Digital Health Platform

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., announced a new collaboration with Rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives.

November 14, 2022
·
7 min read
Biotech Beach

Equillium Announces Data Suggesting Soluble ALCAM as a Potential Biomarker of Disease Severity in Lupus Nephritis at ACR Convergence 2022

Equillium, Inc. today announced that a poster presentation was given over the weekend at ACR Convergence, the annual meeting of the American College of Rheumatology.

November 14, 2022
·
6 min read
Business

Immunome Reports Third Quarter 2022 Financial Results

Immunome, Inc. today reported financial results for the third quarter ended September 30, 2022 and provided a corporate update.

November 14, 2022
·
8 min read